Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
Iambic Therapeutics, Inc
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)
Columbia University
ABM Therapeutics Corporation
Wake Forest University Health Sciences
Second Affiliated Hospital of Guangzhou Medical University
National Cancer Institute (NCI)
University of Florida
Mayo Clinic
Quadriga Biosciences, Inc.
IGF Oncology, LLC
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
SWOG Cancer Research Network
National Cancer Institute (NCI)
Angiochem Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center